84 related articles for article (PubMed ID: 16111298)
1. [RA-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, and anti-FRP antibodies)].
Tanaka M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():449-52. PubMed ID: 16111298
[No Abstract] [Full Text] [Related]
2. [Rheumatoid arthritis-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, anti-FRP antibodies)].
Kubota T
Nihon Rinsho; 2010 Jun; 68 Suppl 6():488-90. PubMed ID: 20942110
[No Abstract] [Full Text] [Related]
3. [Novel autoantibodies and their target antigens in rheumatoid arthritis].
Mimori T; Tanaka M
Nihon Rinsho; 2002 Dec; 60(12):2263-8. PubMed ID: 12510348
[TBL] [Abstract][Full Text] [Related]
4. [Anti-calpastatin antibody as a serological marker for the diagnosis of rheumatoid arthritis].
Matsuno H; Ochiai A; Iwaki-Egawa S; Watanabe Y
Nihon Rinsho; 2005 Jan; 63 Suppl 1():344-50. PubMed ID: 15799375
[No Abstract] [Full Text] [Related]
5. [Antigenic epitopes recognized by autoantibodies to calpastatin in patients with rheumatoid arthritis and their clinical significance].
Yasuoka H; Sugano Y; Oka T; Watanabe C; Kaneko Y; Nojima T; Matsumura M; Fujii T; Mimori T
Ryumachi; 1997 Jun; 37(3):458-66. PubMed ID: 9256029
[TBL] [Abstract][Full Text] [Related]
6. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen.
Iwaki-Egawa S; Matsuno H; Yudoh K; Nakazawa F; Miyazaki K; Ochiai A; Hirohata S; Shimizu M; Watanabe Y
J Rheumatol; 2004 Jan; 31(1):17-22. PubMed ID: 14705213
[TBL] [Abstract][Full Text] [Related]
7. [The new serological markers of rheumatoid arthritis].
Tuchocka-Piotrowska A; Puszczewicz M
Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699
[TBL] [Abstract][Full Text] [Related]
8. Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis.
Tanaka M; Kishimura M; Ozaki S; Osakada F; Hashimoto H; Okubo M; Murakami M; Nakao K
J Clin Invest; 2000 Jul; 106(1):137-44. PubMed ID: 10880057
[TBL] [Abstract][Full Text] [Related]
9. [Immunologic tests: Anti citrullinated protein (filaggrin/CCP) antibodies].
Mimori T
Nihon Rinsho; 2005 Jul; 63 Suppl 7():472-5. PubMed ID: 16111305
[No Abstract] [Full Text] [Related]
10. [Abnormal gp130 signaling and autoimmune disease].
Ishihara K; Atsumi T
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2336-42. PubMed ID: 12518458
[No Abstract] [Full Text] [Related]
11. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.
Scheller J; Kovaleva M; Rabe B; Eichler J; Kallen KJ; Rose-John S
J Immunol Methods; 2004 Aug; 291(1-2):93-100. PubMed ID: 15345308
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
13. [Anti-cyclic citrullinated peptide (CCP) antibodies].
Mimori T
Nihon Rinsho; 2010 Jun; 68 Suppl 6():491-4. PubMed ID: 20942111
[No Abstract] [Full Text] [Related]
14. [Interleukin-6 in pathogenesis of rheumatoid arthritis].
Mihara M; Nishimoto N
Nihon Rinsho; 2005 Jan; 63 Suppl 1():158-62. PubMed ID: 15799337
[No Abstract] [Full Text] [Related]
15. Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies.
Escalona M; López-Longo FJ; González CM; Monteagudo I; Rodríguez-Mahou M; Grau R; Carreño L
J Rheumatol; 2002 Oct; 29(10):2053-60. PubMed ID: 12375311
[TBL] [Abstract][Full Text] [Related]
16. Novel autoantibody markers for early and seronegative rheumatoid arthritis.
Somers K; Geusens P; Elewaut D; De Keyser F; Rummens JL; Coenen M; Blom M; Stinissen P; Somers V
J Autoimmun; 2011 Feb; 36(1):33-46. PubMed ID: 21071175
[TBL] [Abstract][Full Text] [Related]
17. [Detection of isotype-specific autoantibodies to calpastatin in sera from patients with rheumatic diseases using heat-treated HeLa cell extract as an antigen source for immunoblotting].
Takada R; Matsumoto M; Yosida M; Nojima T; Hirakata M; Ohosone Y; Mimori T
Nihon Rinsho Meneki Gakkai Kaishi; 1998 Aug; 21(4):150-8. PubMed ID: 9793376
[TBL] [Abstract][Full Text] [Related]
18. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
[TBL] [Abstract][Full Text] [Related]
19. [Predictive factors in prognosis of rheumatoid arthritis].
Matsuda T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():19-23. PubMed ID: 15799311
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
